Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
781 000 KRW
Updated:
May 15, 2024
Balance Sheet
Balance Sheet Decomposition
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
| Current Assets | 5.4T |
| Cash & Short-Term Investments | 1.8T |
| Receivables | 895.4B |
| Other Current Assets | 2.7T |
| Non-Current Assets | 10.5T |
| Long-Term Investments | 39B |
| PP&E | 4.3T |
| Intangibles | 5.9T |
| Other Non-Current Assets | 291.8B |
| Current Liabilities | 4.1T |
| Accounts Payable | 164.5B |
| Accrued Liabilities | 284.3B |
| Short-Term Debt | 509.5B |
| Other Current Liabilities | 3.1T |
| Non-Current Liabilities | 2.2T |
| Long-Term Debt | 487.6B |
| Other Non-Current Liabilities | 1.7T |
Balance Sheet
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
96 287
|
34 510
|
230 338
|
358 088
|
17 622
|
125 101
|
28 850
|
47 410
|
890 820
|
367 937
|
|
| Cash Equivalents |
96 287
|
34 510
|
230 338
|
358 088
|
17 622
|
125 101
|
28 850
|
47 410
|
890 820
|
367 937
|
|
| Short-Term Investments |
0
|
0
|
970 000
|
0
|
1 090 081
|
530 040
|
800 046
|
1 300 040
|
2 280 885
|
1 654 513
|
|
| Total Receivables |
28 694
|
37 009
|
75 631
|
25 817
|
141 833
|
207 930
|
246 197
|
430 242
|
820 156
|
742 712
|
|
| Accounts Receivables |
15 266
|
35 031
|
69 609
|
19 355
|
135 951
|
205 873
|
245 797
|
430 242
|
820 156
|
742 712
|
|
| Other Receivables |
13 428
|
1 978
|
6 022
|
6 462
|
5 882
|
2 057
|
400
|
0
|
0
|
0
|
|
| Inventory |
74 402
|
119 177
|
164 220
|
209 987
|
302 361
|
452 470
|
645 960
|
1 012 871
|
2 375 819
|
2 641 368
|
|
| Other Current Assets |
17 455
|
2 157
|
21 236
|
27 103
|
25 788
|
40 720
|
30 294
|
32 613
|
89 977
|
115 457
|
|
| Total Current Assets |
216 838
|
192 854
|
1 461 425
|
620 995
|
1 577 684
|
1 356 262
|
1 751 347
|
2 823 175
|
6 457 657
|
5 521 988
|
|
| PP&E Net |
761 294
|
890 256
|
1 090 960
|
1 513 333
|
1 717 721
|
1 718 911
|
1 760 728
|
2 227 687
|
3 871 452
|
4 342 424
|
|
| PP&E Gross |
761 294
|
890 256
|
1 090 960
|
1 513 333
|
1 717 721
|
1 718 911
|
1 760 728
|
2 227 687
|
3 871 452
|
4 342 424
|
|
| Accumulated Depreciation |
36 257
|
51 490
|
107 274
|
171 109
|
256 228
|
376 961
|
506 623
|
647 011
|
817 873
|
1 057 354
|
|
| Intangible Assets |
312 219
|
14 286
|
14 045
|
18 999
|
19 982
|
21 828
|
23 345
|
32 172
|
4 283 699
|
4 154 480
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 677 608
|
1 677 608
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
77 079
|
131 071
|
197 863
|
193 759
|
188 262
|
254 469
|
|
| Long-Term Investments |
53 922
|
4 837 539
|
4 944 356
|
5 008 234
|
2 561 803
|
2 673 493
|
2 654 676
|
2 661 309
|
30 775
|
40 096
|
|
| Other Long-Term Assets |
11 425
|
25 559
|
22 230
|
21 530
|
26 140
|
10 063
|
36 242
|
31 907
|
72 598
|
55 133
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 677 608
|
1 677 608
|
|
| Total Assets |
1 355 698
N/A
|
5 960 494
+340%
|
7 533 016
+26%
|
7 183 091
-5%
|
5 980 409
-17%
|
5 911 627
-1%
|
6 424 201
+9%
|
7 970 011
+24%
|
16 582 050
+108%
|
16 046 197
-3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
957
|
358
|
1 521
|
14 479
|
3 811
|
12 290
|
54 984
|
32 251
|
59 616
|
208 278
|
|
| Accrued Liabilities |
62 005
|
28 341
|
23 046
|
28 670
|
49 777
|
43 876
|
64 356
|
74 322
|
207 437
|
281 317
|
|
| Short-Term Debt |
48 526
|
10 109
|
0
|
40 000
|
90 000
|
150 000
|
30 000
|
50 000
|
582 783
|
654 500
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
403 694
|
98 677
|
296 583
|
254 899
|
167 440
|
117 392
|
698 264
|
877 436
|
|
| Other Current Liabilities |
125 306
|
1 872 861
|
2 048 284
|
2 105 616
|
270 359
|
229 440
|
272 521
|
833 330
|
2 633 441
|
2 136 331
|
|
| Total Current Liabilities |
236 794
|
1 911 669
|
2 476 545
|
2 287 442
|
710 530
|
690 505
|
589 301
|
1 107 295
|
4 181 542
|
4 157 861
|
|
| Long-Term Debt |
427 199
|
681 792
|
439 363
|
407 236
|
486 113
|
248 808
|
587 465
|
1 125 355
|
1 232 986
|
377 397
|
|
| Deferred Income Tax |
0
|
581 574
|
526 671
|
505 316
|
534 542
|
470 545
|
449 847
|
487 712
|
1 214 216
|
1 184 420
|
|
| Minority Interest |
32 592
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
200
|
|
| Other Liabilities |
60 973
|
10 624
|
8 058
|
6 647
|
93 755
|
147 315
|
198 804
|
258 547
|
968 833
|
495 827
|
|
| Total Liabilities |
757 558
N/A
|
3 185 660
+321%
|
3 450 637
+8%
|
3 206 640
-7%
|
1 824 940
-43%
|
1 557 173
-15%
|
1 825 418
+17%
|
2 978 909
+63%
|
7 597 576
+155%
|
6 215 705
-18%
|
|
| Equity | |||||||||||
| Common Stock |
101 833
|
137 844
|
165 413
|
165 413
|
165 413
|
165 413
|
165 413
|
165 413
|
177 935
|
177 935
|
|
| Retained Earnings |
314 664
|
1 601 530
|
1 424 707
|
1 327 735
|
1 509 719
|
1 712 623
|
1 953 598
|
2 347 187
|
3 145 601
|
4 003 293
|
|
| Additional Paid In Capital |
808 874
|
1 039 891
|
2 496 583
|
2 496 583
|
2 496 583
|
2 496 583
|
2 496 627
|
2 496 627
|
6 523 004
|
6 523 004
|
|
| Unrealized Security Profit/Loss |
15 229
|
9 664
|
11 368
|
4 601
|
5 564
|
5 433
|
3 695
|
4 177
|
4 992
|
0
|
|
| Other Equity |
13 132
|
14 095
|
15 691
|
17 880
|
21 811
|
25 598
|
20 549
|
22 302
|
867 058
|
873 739
|
|
| Total Equity |
598 140
N/A
|
2 774 834
+364%
|
4 082 379
+47%
|
3 976 451
-3%
|
4 155 468
+5%
|
4 354 454
+5%
|
4 598 783
+6%
|
4 991 102
+9%
|
8 984 474
+80%
|
9 830 492
+9%
|
|
| Total Liabilities & Equity |
1 355 698
N/A
|
5 960 494
+340%
|
7 533 016
+26%
|
7 183 091
-5%
|
5 980 409
-17%
|
5 911 627
-1%
|
6 424 201
+9%
|
7 970 011
+24%
|
16 582 050
+108%
|
16 046 197
-3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
55
|
55
|
66
|
66
|
66
|
66
|
66
|
67
|
71
|
71
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
